2024-514426-23-01CompletedPhase 1
A Phase 1, Open-Label, Multiple-Part Trial to Evaluate the Drug-Drug Interaction Potential of PRAX-628 in Healthy Participants
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Dec 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 62 (actual)
- First submitted
- 4 Jul 2024
- Start date
- 28 Aug 2024
- Lead sponsor
- Praxis Precision Medicines Inc.
- EU CT number
- 2024-514426-23-01
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 62
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pharmaceutical Research Associates Group B.V. | Groningen | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.